Shanghai Ankang Pharmaceutical Co.,LTD   Report issue

For profit
Founded: Shanghai China (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2010
NCT01125241
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

wuling (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1